Robocath was bought by Stereotaxis
French cardiovascular and neurovascular robotic assistance systems developer Robocath was bought by US-based robotic cardiac navigation systems provider Stereotaxis for $20M to expand its robotic endovascular portfolio and support the development of next-generation robotic systems.